Outsourced Pharma Webinars

1. Improving Clinical Translation For ADCs And Immuno-Oncology With Human-Relevant Tumor Models 9/17/2026

   When preclinical tumor models fail to reflect clinical reality, promising therapies pay the price. This webinar examines how advanced patient-derived organoids and 3D models improve predictive accuracy for ADC and immuno-oncology programs.

2. A Smarter Microbial Approach To Therapeutic Peptide Manufacturing 9/17/2026

   See how microbial expression can improve therapeutic peptide yields, reduce costs, and simplify downstream processing while supporting development from research through manufacturing.

3. Establishing A Risk-Based Containment Strategy For High-Potency Micronization 9/16/2026

   This session presents a risk-based framework for high-potency micronisation, illustrated through a practical case study that spans development to commercial scale.

4. Scaling AAV Manufacturing To 1000 L: Strategies For Robust Production 9/15/2026

   Learn how integrated cell line, media, and process design can support consistent AAV production at larger volumes while maintaining productivity and quality, as well as reducing scale-up risk.

5. The Next Generation Of USP <87> Testing 9/14/2026

   Upcoming USP <87> changes are driving risk-based in vitro testing. Learn how to prepare for new requirements, validation impacts, and continued compliance.

6. Reducing Timelines And Development Costs Through Scale Up 9/11/2026

   See how an engineering-based approach to bioreactor scale-up delivered comparable cell growth, metabolic profiles, and product performance across cell lines and vessel sizes, helping reduce risks.

7. Scaling AAV Purification: UF/DF Technologies That Deliver 9/11/2026

   Examine a data-driven comparison of hollow-fiber and flat-sheet TFF technologies for AAV manufacturing, covering process performance, scalability, engineering considerations, and cost.

8. Continuous Lyophilization: Accelerating Freeze-Drying Development 9/9/2026

   Continuous lyophilization is compressing freeze-drying cycle times from days to hours. This webinar examines how the approach is being implemented in development labs with a path to GMP manufacturing.

9. Beyond Breakdowns: Building A Culture Of Proactive Maintenance 9/8/2026

   Reactive maintenance can drive costly downtime, deviations, and reliability challenges. Learn how proactive maintenance strategies help improve equipment uptime and strengthen compliance.

10. Overcome Early Development Challenges Before They Impact Your Program 9/3/2026

    Poor manufacturability and immunogenicity can delay development. Learn how early developability assessments support IND readiness.